CSL Vifor and Travere Therapeutics Support Updated KDIGO IgA Nephropathy Guidelines
September 26, 2025
CSL Vifor and Travere Therapeutics, Inc. support the recent publication of the updated clinical practice guidelines for the treatment of IgA Nephropathy (IgAN), Kidney Disease: